ArticleFrontiers in medicine2025
PSOA-LSTM: a hybrid attention-based LSTM model optimized by particle swarm optimization for accurate lung cancer incidence forecasting in China (1990-2021).
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PSO-BiLSTM-Attention: An Interpretable Deep Learning Model Optimized by Particle Swarm Optimization for Accurate Ischemic Heart Disease Incidence Forecasting.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate forecasting of lung cancer incidence is crucial for early prevention, effective medical resource allocation, and evidence-based policymaking. Objective: This study proposes a novel deep learning framework-PSOA-LSTM-that integrates Particle Swarm Optimization (PSO) with an attention-based Long Short-Term Memory (LSTM) network to enhance the precision of lung cancer incidence prediction. Methods: Using the Global Burden of Disease 2019 (GBD 2019) dataset, the model predicts age- and gender-specific lung cancer incidence trends for the next 5 years. The proposed model was compared against traditional models including ARIMA, standard LSTM, Support Vector Regression (SVR), and Random Forest (RF). Results: The PSOA-LSTM model achieved superior performance across five key evaluation metrics: mean squared error (MSE) = 0.023, coefficient of determination ( Conclusion: The proposed PSOA-LSTM model outperforms benchmark models in predicting lung cancer incidence across demographic segments, offering a reliable decision-support tool for public health surveillance, early warning systems, and health policy formulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.